Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Computer Aided Drug Design and Molecular Modeling Lab, Department of Bioinformatics, Science Block, Alagappa University, Karaikudi, Tamilnadu, India.
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.
COVID-19 (Coronavirus disease 2019) is a transmissible disease initiated and propagated through a new virus strain SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) since 31 December 2019 in Wuhan city of China and the infection has outspread globally influencing millions of people. Here, an attempt was made to recognize natural phytochemicals from medicinal plants, in order to reutilize them against COVID-19 by the virtue of molecular docking and molecular dynamics (MD) simulation study. Molecular docking study showed six probable inhibitors against SARS-CoV-2 M (Main protease), two from (Ashwagandha) (Withanoside V [10.32 kcal/mol] and Somniferine [9.62 kcal/mol]), one from (Giloy) (Tinocordiside [8.10 kcal/mol]) and three from (Tulsi) (Vicenin [8.97 kcal/mol], Isorientin 4'--glucoside 2″---hydroxybenzoagte [8.55 kcal/mol] and Ursolic acid [8.52 kcal/mol]). ADMET profile prediction showed that the best docked phytochemicals from present work were safe and possesses drug-like properties. Further MD simulation study was performed to assess the constancy of docked complexes and found stable. Hence from present study it could be suggested that active phytochemicals from medicinal plants could potentially inhibit M of SARS-CoV-2 and further equip the management strategy against COVID-19-a global contagion. HighlightsHolistic approach of Ayurvedic medicinal plants to avenge against COVID-19 pandemic.Active phytoconstituents of Ayurvedic medicinal plants (Ashwagandha), (Giloy) and (Tulsi) predicted to significantly hinder main protease (M or 3Cl) of SARS-CoV-2.Through molecular docking and molecular dynamic simulation study, Withanoside V, Somniferine, Tinocordiside, Vicenin, Ursolic acid and Isorientin 4'--glucoside 2″---hydroxybenzoagte were anticipated to impede the activity of SARS-CoV-2 M.Drug-likeness and ADMET profile prediction of best docked compounds from present study were predicted to be safe, drug-like compounds with no toxicity.Communicated by Ramaswamy H. Sarma.
新型冠状病毒肺炎(COVID-19)是一种由新型冠状病毒 SARS-CoV-2 引起的传染病,自 2019 年 12 月 31 日在中国武汉市爆发以来,该病毒已在全球范围内传播,影响了数百万人。在这里,我们试图从药用植物中识别天然植物化学物质,以便通过分子对接和分子动力学(MD)模拟研究重新利用它们来对抗 COVID-19。分子对接研究表明,有六种可能的 SARS-CoV-2 M(主要蛋白酶)抑制剂,其中两种来自 (Ashwagandha)(Withanoside V[10.32 kcal/mol]和 Somniferine[9.62 kcal/mol]),一种来自 (Giloy)(Tinocordiside[8.10 kcal/mol]),三种来自 (Tulsi)(Vicenin[8.97 kcal/mol],Isorientin 4'--glucoside 2″---hydroxybenzoagte[8.55 kcal/mol]和 Ursolic acid[8.52 kcal/mol])。ADMET 特性预测表明,目前工作中最佳对接的植物化学物质是安全的,具有类药性。进一步进行 MD 模拟研究以评估对接复合物的稳定性,发现其稳定。因此,从目前的研究中可以得出结论,药用植物中的活性植物化学物质可能具有抑制 SARS-CoV-2 M 的潜力,并进一步为对抗 COVID-19 这一全球性传染病提供管理策略。 亮点 阿育吠陀药用植物的整体方法来对抗 COVID-19 大流行。 阿育吠陀药用植物 (Ashwagandha)、 (Giloy)和 (Tulsi)中的活性植物成分被预测可显著抑制 SARS-CoV-2 的主要蛋白酶(M 或 3Cl)。 通过分子对接和分子动力学模拟研究,Withanoside V、Somniferine、Tinocordiside、Vicenin、Ursolic acid 和 Isorientin 4'--glucoside 2″---hydroxybenzoagte 被预期可以阻止 SARS-CoV-2 M 的活性。 从目前的研究中预测出最佳对接化合物的药物相似性和 ADMET 特性预测是安全的、类药性的化合物,没有毒性。 由 Ramaswamy H. Sarma 传达。